Souhaitez-vous accéder aux communiqués récents ?

SAN FRANCISCO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- A comprehensive systematic review of lifestyle interventions to prevent cognitive decline, which published in the prestigious British medical journal...

SAN FRANCISCO, Oct. 21, 2025 (GLOBE NEWSWIRE) -- The NIH has awarded a new grant to Posit Science, the maker of the online BrainHQ brain exercises, to advance research, which showed in a...

SAN FRANCISCO, Oct. 14, 2025 (GLOBE NEWSWIRE) -- A new peer-reviewed brain imaging study shows a novel intervention can significantly upregulate the production of a key brain chemical —...

SAN FRANCISCO, July 07, 2025 (GLOBE NEWSWIRE) -- For the first time, a study shows a digital assessment can provide a scientific measure of acetylcholine – a key brain chemical whose decline signals...

Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Muscarinic Acetylcholine Receptor M1 Antagonists - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This...

Dublin, Jan. 11, 2023 (GLOBE NEWSWIRE) -- The "Migraine Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...

Dublin, June 20, 2022 (GLOBE NEWSWIRE) -- The "Botulinum Toxin - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Botulinum Toxin Market...

Dublin, Oct. 22, 2021 (GLOBE NEWSWIRE) -- The "Migraine Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to...

Dublin, Dec. 15, 2020 (GLOBE NEWSWIRE) -- The "Migraine Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to...

SAN FRANCISCO, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Posit Science, the maker of BrainHQ computerized brain exercises, has been awarded a federal grant to measure the impact of BrainHQ training on the...